ASPN ASPEN AEROGELS INC
Wholesale-Lumber & Other Construction Materials · NYSE · SEC CIK 1145986 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-39.3%
TTM net income YoY57.3%
TTM EPS YoY57.7%
Revenue 3-yr CAGR0.0%
Net income 3-yr CAGR—
Margins
Gross margin2.4%
Operating margin-59.3%
Net margin-60.8%
FCF margin9.3%
EBITDA margin-39.4%
Returns
ROE-53.2%
ROA-29.4%
ROIC (approx.)-55.3%
Asset turnover0.48x
Leverage & solvency
Liabilities / assets53.2%
Debt / equity0.40x
Current ratio2.10x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.23x
Accruals ratio-36.3%
Payout ratio—
Capex / revenue4.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $271.10M | $452.70M |
| Cost of revenue | $225.10M | $269.80M |
| Gross profit | $46.00M | $182.90M |
| R&D expense | $13.42M | $18.05M |
| SG&A expense | $55.77M | $71.12M |
| Operating income | -$378.23M | $54.53M |
| Pretax income | -$387.16M | $15.09M |
| Income tax | $2.39M | $1.71M |
| Net income | -$389.55M | $13.38M |
| EBITDA | -$333.07M | $77.06M |
| EPS (basic) | -4.73 | 0.17 |
| EPS (diluted) | -4.73 | 0.17 |
| Weighted avg. shares (diluted) | 82.33M | 80.31M |
| Banking | ||
| Net interest income | $7.50M | $5.70M |
| Balance sheet | ||
| Cash & equivalents | $156.86M | $220.88M |
| Receivables | $35.27M | $109.10M |
| Inventory | $38.25M | $47.55M |
| Current assets | $242.05M | $409.45M |
| PP&E, net | $98.40M | $459.28M |
| Total assets | $406.68M | $895.14M |
| Current liabilities | $62.02M | $110.11M |
| Short-term debt | $25.11M | $19.75M |
| Long-term debt | $65.45M | $94.96M |
| Total debt | $90.57M | $114.71M |
| Total liabilities | $171.16M | $280.44M |
| Shareholders' equity | $235.52M | $614.71M |
| Net debt | -$66.29M | -$106.17M |
| Shares outstanding | 82.71M | 82.04M |
| Cash flow statement | ||
| Operating cash flow | $32.87M | $45.55M |
| Capital expenditure | $37.45M | $86.26M |
| Free cash flow | -$4.58M | -$40.71M |
| Investing cash flow | -$37.45M | -$86.26M |
| Financing cash flow | -$58.13M | $122.02M |
| Depreciation & amortization | $45.16M | $22.53M |
| Stock-based compensation | $8.63M | $12.86M |
Free plan shows the latest 2 periods; Pro shows all 14 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.